Peak Retirement Planning Inc. Acquires Shares of 3,632 CME Group Inc. (NASDAQ:CME)

Peak Retirement Planning Inc. purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,632 shares of the financial services provider's stock, valued at approximately $843,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. SJS Investment Consulting Inc. raised its holdings in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares during the period. New Age Alpha Advisors LLC raised its holdings in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Financial Life Planners acquired a new stake in shares of CME Group during the fourth quarter worth $32,000. Knuff & Co LLC acquired a new stake in shares of CME Group during the fourth quarter worth $33,000. Finally, Banque Transatlantique SA acquired a new stake in shares of CME Group during the fourth quarter worth $35,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Price Performance

CME traded up $1.62 on Wednesday, reaching $285.98. The company had a trading volume of 2,295,825 shares, compared to its average volume of 2,190,500. The company has a fifty day moving average of $268.56 and a 200-day moving average of $250.00. The company has a market capitalization of $103.06 billion, a P/E ratio of 29.57, a PEG ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a one year low of $190.70 and a one year high of $287.04.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.50 EPS. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is 50.30%.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the sale, the director now directly owns 5,400 shares of the company's stock, valued at approximately $1,471,824. This represents a 35.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares of the company's stock, valued at $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 28,384 shares of company stock valued at $7,531,053. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have weighed in on CME shares. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday. Oppenheimer increased their target price on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a report on Friday, April 11th. Piper Sandler upped their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Barclays upped their price target on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Finally, Bank of America upped their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.